Financials
Financial year 2025
VM Pharma from Watermaal-Bosvoorde, company number BE0743948725, closed financial year 2025 with a result of € -17,906 after tax. For that financial year VM Pharma recorded a gross margin of € 131,435 and equity of € 242,551. Compared with financial year 2024, the result moved from € 14,987 to € -17,906. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 4, 2026.
€ 242,551
▼ 7% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -17,906
▼ still € 14,987 profit in 2024
Profit after tax over the fiscal year.
€ 54,967
▲ € 45,553 vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 192,551.
People and assets in 2025
€ 77,835
▲ 28% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,708
▼ 48% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 60,741
▼ 24% vs 2024
€ 18,176 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 165,592
▲ € 139,802 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 25,195
▼ 3% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 213,180 | € 131,523 | € 174,740 | € 131,435 | ▼ 25% |
| Profit after taxes | € 92,490 | € 28,895 | € 14,987 | € -17,906 | ▼ € 32,892 |
| Equity | € 216,574 | € 245,470 | € 260,457 | € 242,551 | ▼ 7% |
| Total debts | € 237,520 | € 169,261 | € 131,987 | € 286,174 | ▲ 117% |
| Cash | € 126,714 | € 24,828 | € 9,415 | € 54,967 | ▲ € 45,553 |
| Retained profit | € 166,574 | € 195,470 | € 210,457 | € 192,551 | ▼ 9% |
| Bank debt | € 116,460 | € 98,739 | € 79,932 | € 60,741 | ▼ 24% |
| Balance sheet total | € 454,095 | € 414,731 | € 392,444 | € 528,725 | ▲ 35% |
By gross margin, VM Pharma ranks 5th of 7 companies with main activity “Detailhandel in farmaceutische producten” in Watermaal-Bosvoorde that publish figures (fiscal year 2025).
Key figures of VM Pharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about VM Pharma the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to VM Pharma?
What happened at VM Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 17,906 (▼ € 32,892 vs 2024). filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Watermaal-Bosvoorde. KBO
In short
From € 92,490 profit in 2022 to € 17,906 loss in 2025.
Paid € 44,682 in corporate taxes since 2022.
Best year ever: 2022, with € 92,490 profit.
Management
Behind VM Pharma is Vincenzo Mollica. Vincenzo Mollica is also behind LES LABORATOIRES REPOUSS.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Théophile Vander Elststraat 42
1170 Watermaal-Bosvoorde
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Watermaal-Bosvoorde
Same main activity (Detailhandel in farmaceutische producten), 9 active companies in Watermaal-Bosvoorde, largest first.
€ 851,683 gross margin · 2025
€ 522,210 gross margin · 2025
€ 499,060 gross margin · 2025
€ 235,043 gross margin · 2025
€ 103,955 gross margin · 2025
€ 97,965 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- MOLLICA Vincenzo(oprichter) 100%
Details
- Company number
- 0743.948.725
- VAT number
- BE 0743.948.725
- Registered office
- Théophile Vander Elststraat 42, 1170 Watermaal-Bosvoorde
- Names & denominations
- VM Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 21 February 2020
- Peppol
- Active · Active since 23 Sept 2025
- Activities · NACE
Detailhandel in farmaceutische producten